Innovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
4 years agoInnovations addressing the challenges of oncology clinical research to treat rare and ultra-rare diseases
Rare cancers are notoriously difficult to study and present a critical problem in clinical research. Innovations to clinical trial design and patient recruitment are some of the many changes in the field to optimise the outcome of clinical trials for...
4 years ago
Are CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years agoAre CAR-T and TCR Therapies The Future for Cancer Patients?
Cancer represents one of the most complex diseases in the world. The vast number of cancer types that vary in pathology and response to treatment continue to pose a problem. CAR-T and TCR therapies represent the next step in developing...
4 years ago
Evaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years agoEvaluating The Efficacy of Therapeutic Oncology Vaccines in Cancer Treatment
The development of anti-cancer vaccines is supported by many studies which prove the efficacy of immunotherapy against cancer. Cancer vaccines are also the beginning of preventative treatment for many cancer types, offering hope for susceptible patient populations. The latest advancements...
4 years ago
Innovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years agoInnovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years ago
Data Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years agoData Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years ago
Personalised Medicine Strategies – Providing More Clinical Benefit
Current personalised medicine strategies provide limited clinical benefit – how do we do better? Luckily Dr Allan Jordan, the Director of Oncology Drug Discovery at leading CRO Sygnature Discovery, was on hand to explain how. Here's another chance to watch...
4 years agoPersonalised Medicine Strategies – Providing More Clinical Benefit
Current personalised medicine strategies provide limited clinical benefit – how do we do better? Luckily Dr Allan Jordan, the Director of Oncology Drug Discovery at leading CRO Sygnature Discovery, was on hand to explain how. Here's another chance to watch...
4 years ago
Avoiding Bias in Precision Medicine
Precision medicine, or the tailoring of healthcare towards either a select group or individual based on their needs and physiology instead of their illness, is a well-known and highly-anticipated aspect of healthcare pharmaceuticals, with thousands of articles written on it. ...
5 years agoAvoiding Bias in Precision Medicine
Precision medicine, or the tailoring of healthcare towards either a select group or individual based on their needs and physiology instead of their illness, is a well-known and highly-anticipated aspect of healthcare pharmaceuticals, with thousands of articles written on it. ...
5 years ago